ACTINOGEN MEDICAL LIMITED - Announcements

1.79%

2.8¢

Market Cap $85.73M

Healthcare Biotechnology

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel... Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long term cognitive health.More

Corporate Spotlight

Actinogen is a neurotherapeutics developer realizing a revolutionary therapy so neurology patients and their families can live their best lives.
View the full Corporate Spotlight

Actinogen reaches 100th participant milestone

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

ACW	Appendix 4E & Financial Statements	PRICE SENSITIVE	31/08/15	1.12MB	Share
ACW	Clinical Trial Successfully Completed with Xanamem	PRICE SENSITIVE	11/08/15	112.92KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	16/07/15	83.95KB	Share
ACW	Excellent Research Progress with Promising Alzheimers Drug	PRICE SENSITIVE	11/06/15	106.42KB	Share
ACW	Successful Completion of 1st Stage of Alzheimer's Drug Trial	PRICE SENSITIVE	12/05/15	106.59KB	Share
ACW	Share Purchase Plan	PRICE SENSITIVE	30/04/15	454.15KB	Share
ACW	Ethics Approval Granted for 2nd Stage of Phase 1 Study	PRICE SENSITIVE	24/04/15	105.67KB	Share
ACW	Appendix 4C	PRICE SENSITIVE	24/04/15	85.6KB	Share
ACW	Successful Capital Raising to Support Alzheimers Research	PRICE SENSITIVE	24/04/15	128.73KB	Share
ACW	Trading Halt	PRICE SENSITIVE	22/04/15	201.58KB	Share
ACW	Further Clinical Trial Update on Xanamem	PRICE SENSITIVE	16/04/15	106.28KB	Share
ACW	EU Patent Granted-Further Extends Xanamem Protection	PRICE SENSITIVE	13/04/15	160.75KB	Share
ACW	Clinical Trial Update-Xanamem Drug for Alzheimers Dementia	PRICE SENSITIVE	24/03/15	104.7KB	Share
ACW	Response to Price Query Letter	PRICE SENSITIVE	12/03/15	138.12KB	Share
ACW	Appendix 4D & Half-Year Financial Statements	PRICE SENSITIVE	27/02/15	898.76KB	Share
ACW	First Participants Recruited for 2nd Phase 1 Xanamem Study	PRICE SENSITIVE	24/02/15	107.66KB	Share
ACW	Ethics Approval Granted for Second Phase 1 Study of Xanamem	PRICE SENSITIVE	16/02/15	106.82KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/15	89.07KB	Share
ACW	Resonse to ASX Query - Price Query	PRICE SENSITIVE	07/01/15	137.48KB	Share
ACW	Actinogen Board Changes	PRICE SENSITIVE	18/12/14	88.27KB	Share
ACW	Actinogen Medical Appoints Dr Bill Ketelbey as CEO	PRICE SENSITIVE	15/12/14	130.59KB	Share
ACW	R&D Tax Rebate Received	PRICE SENSITIVE	01/12/14	68.09KB	Share
ACW	New Patents Allowed for B-HSD1 Inhibitor	PRICE SENSITIVE	05/11/14	110.05KB	Share
ACW	Appendix 4C & Commentary	PRICE SENSITIVE	23/10/14	189.62KB	Share
ACW	Capital Raising	PRICE SENSITIVE	27/08/14	52.26KB	Share
ACW	Actinogen to acquire Corticrine Limited	PRICE SENSITIVE	27/08/14	171.53KB	Share
ACW	Trading Halt	PRICE SENSITIVE	26/08/14	106.11KB	Share
ACW	Appendix 4E & Financial Statements	PRICE SENSITIVE	01/08/14	1.22MB	Share
ACW	Appendix 4C & Commentary	PRICE SENSITIVE	31/07/14	140.87KB	Share
ACW	Actinogen Isolates Demonstrate Antitumorigenic Activity	PRICE SENSITIVE	13/06/14	40.6KB	Share
ACW	Appendix 4C & Commentary	PRICE SENSITIVE	16/04/14	131.49KB	Share
ACW	Appendix 4D & Half-Year Financial Statements	PRICE SENSITIVE	27/02/14	504.02KB	Share
ACW	Actinogen & Curtin Uni to Work on Cancer Stem Cells	PRICE SENSITIVE	27/02/14	34.07KB	Share
ACW	TRIALS RECOMMENCE ON ANTIBIOTIC PROJECT	PRICE SENSITIVE	12/02/14	115.11KB	Share
ACW	Appendix 4C & Commentary	PRICE SENSITIVE	23/01/14	107.89KB	Share
ACW +FGH	Actinogen Ltd Collaboration	PRICE SENSITIVE	23/12/13	492.26KB	Share
ACW +FGH	Leaf to Fund First Trial on Actingoen's Bioethanol Project	PRICE SENSITIVE	23/12/13	34.84KB	Share
ACW	Placement, Appendix 3B & Section 708A Notice	PRICE SENSITIVE	12/12/13	195.94KB	Share
ACW	R&D Tax Rebate Received	PRICE SENSITIVE	28/11/13	44.9KB	Share
ACW	Activity Report & Appendix 4C	PRICE SENSITIVE	29/10/13	127.53KB	Share
ACW	Closure of laboratory	PRICE SENSITIVE	12/09/13	57.22KB	Share
ACW	Actinogen to receive further funding from Otsana Capital	PRICE SENSITIVE	11/09/13	87.74KB	Share
ACW	Preliminary Final Report	PRICE SENSITIVE	30/08/13	183.66KB	Share
ACW	Market Update and Clarification	PRICE SENSITIVE	29/08/13	1.2MB	Share
ACW	Suspension of ACWN and ACWO 1/08/13	PRICE SENSITIVE	01/08/13	79.81KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/13	144.03KB	Share
ACW	Supplementary prospectus - withdrawal of offer	PRICE SENSITIVE	31/07/13	121.26KB	Share
ACW	Rights Issue Prospectus	PRICE SENSITIVE	02/07/13	1.43MB	Share
ACW	Announcement of non-renounceable rights issue	PRICE SENSITIVE	01/07/13	82.39KB	Share
ACW	New Discovery for Plant Growth in Wheat, Peas and Broad Bean	PRICE SENSITIVE	18/06/13	4.55MB	Share
ACW	Response to ASX Appendix 4C query	PRICE SENSITIVE	10/05/13	4.69MB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/13	144.23KB	Share
ACW	Independent trials being conducted on Plant Growth Hormones	PRICE SENSITIVE	27/03/13	4.56MB	Share
ACW	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	28/02/13	344.06KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/13	143.83KB	Share
ACW	Response to ASX Appendix 4C Query	PRICE SENSITIVE	19/11/12	4.69MB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/12	143.07KB	Share
ACW	Preliminary Final Report	PRICE SENSITIVE	31/08/12	60.28KB	Share
ACW	Response to Appendix 4C ASX Query	PRICE SENSITIVE	13/08/12	4.69MB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	27/07/12	57.23KB	Share
ACW	New Discovery of Making Shikimic Acid	PRICE SENSITIVE	25/07/12	4.56MB	Share
ACW	NEW PATENT APPLICATION FOR BIOFUMIGATION PROCESS	PRICE SENSITIVE	21/05/12	180.21KB	Share
ACW	Rights issue closure and notice of remaining shortfall	PRICE SENSITIVE	16/05/12	208.64KB	Share
ACW	Further results in bio-ethanol test program	PRICE SENSITIVE	01/05/12	510.58KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	26/04/12	160.9KB	Share
ACW	Supplementary prospectus and amended timetable	PRICE SENSITIVE	12/04/12	69.76KB	Share
ACW	Rights issue prospectus (with amended timetable)	PRICE SENSITIVE	27/03/12	1.31MB	Share
ACW	Rights Issue Prospectus	PRICE SENSITIVE	22/03/12	1.3MB	Share
ACW	Bio-ethanol Commercialisation Strategy	PRICE SENSITIVE	20/03/12	427.09KB	Share
ACW	Appendix 4D and Half Yearly Accounts	PRICE SENSITIVE	29/02/12	2.45MB	Share
ACW	Response to ASX query	PRICE SENSITIVE	10/02/12	300KB	Share
ACW	BIOFUEL PROGRAM UPDATE	PRICE SENSITIVE	31/01/12	71.6KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/12	61.97KB	Share
ACW	Update on the Biofuel Research Program	PRICE SENSITIVE	07/12/11	932.08KB	Share
ACW	Actinogen New Discovery in the Biofuel Research Program	PRICE SENSITIVE	09/11/11	189.44KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	27/10/11	160.49KB	Share
ACW	Shareholder Update	PRICE SENSITIVE	03/10/11	177.68KB	Share
ACW	Preliminary Final Report	PRICE SENSITIVE	30/08/11	363.44KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/11	61.07KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/11	137.03KB	Share
ACW	Appendix 4D Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/11	839.78KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/11	57.78KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/10	57.17KB	Share
ACW	Range of Patented Biodegradable Nappies etc to be developed	PRICE SENSITIVE	22/10/10	64.25KB	Share
ACW	Non-Renounceable Rights Issue and Prospectus	PRICE SENSITIVE	08/10/10	1.07MB	Share
ACW	Actinogen scales up Anacardic Acid production	PRICE SENSITIVE	09/09/10	41.82KB	Share
ACW	Preliminary Final Report - Appendix 4E	PRICE SENSITIVE	01/09/10	157.59KB	Share
ACW	Discovery of New Method to produce Anacardic Acid	PRICE SENSITIVE	03/08/10	34.21KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/10	57.03KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/10	57.18KB	Share
ACW	Appendix 4D Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/10	198.23KB	Share
ACW	New Biodegradable Shopping Bags and many other products	PRICE SENSITIVE	11/02/10	80.42KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/10	57.04KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/09	152.94KB	Share
ACW	Preliminary Final Report - Appendix 4E	PRICE SENSITIVE	31/08/09	384.97KB	Share
ACW	Quarterly Appendix 4C	PRICE SENSITIVE	31/07/09	62.46KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/09	147.71KB	Share
ACW	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/09	193.55KB	Share
ACW	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/09	37.69KB	Share

ACW Appendix 4E & Financial Statements
31/08/15	PRICE SENSITIVE	1.12MB	Share
ACW Clinical Trial Successfully Completed with Xanamem
11/08/15	PRICE SENSITIVE	112.92KB	Share
ACW Appendix 4C - quarterly
16/07/15	PRICE SENSITIVE	83.95KB	Share
ACW Excellent Research Progress with Promising Alzheimers Drug
11/06/15	PRICE SENSITIVE	106.42KB	Share
ACW Successful Completion of 1st Stage of Alzheimer's Drug Trial
12/05/15	PRICE SENSITIVE	106.59KB	Share
ACW Share Purchase Plan
30/04/15	PRICE SENSITIVE	454.15KB	Share
ACW Ethics Approval Granted for 2nd Stage of Phase 1 Study
24/04/15	PRICE SENSITIVE	105.67KB	Share
ACW Appendix 4C
24/04/15	PRICE SENSITIVE	85.6KB	Share
ACW Successful Capital Raising to Support Alzheimers Research
24/04/15	PRICE SENSITIVE	128.73KB	Share
ACW Trading Halt
22/04/15	PRICE SENSITIVE	201.58KB	Share
ACW Further Clinical Trial Update on Xanamem
16/04/15	PRICE SENSITIVE	106.28KB	Share
ACW EU Patent Granted-Further Extends Xanamem Protection
13/04/15	PRICE SENSITIVE	160.75KB	Share
ACW Clinical Trial Update-Xanamem Drug for Alzheimers Dementia
24/03/15	PRICE SENSITIVE	104.7KB	Share
ACW Response to Price Query Letter
12/03/15	PRICE SENSITIVE	138.12KB	Share
ACW Appendix 4D & Half-Year Financial Statements
27/02/15	PRICE SENSITIVE	898.76KB	Share
ACW First Participants Recruited for 2nd Phase 1 Xanamem Study
24/02/15	PRICE SENSITIVE	107.66KB	Share
ACW Ethics Approval Granted for Second Phase 1 Study of Xanamem
16/02/15	PRICE SENSITIVE	106.82KB	Share
ACW Appendix 4C - quarterly
29/01/15	PRICE SENSITIVE	89.07KB	Share
ACW Resonse to ASX Query - Price Query
07/01/15	PRICE SENSITIVE	137.48KB	Share
ACW Actinogen Board Changes
18/12/14	PRICE SENSITIVE	88.27KB	Share
ACW Actinogen Medical Appoints Dr Bill Ketelbey as CEO
15/12/14	PRICE SENSITIVE	130.59KB	Share
ACW R&D Tax Rebate Received
01/12/14	PRICE SENSITIVE	68.09KB	Share
ACW New Patents Allowed for B-HSD1 Inhibitor
05/11/14	PRICE SENSITIVE	110.05KB	Share
ACW Appendix 4C & Commentary
23/10/14	PRICE SENSITIVE	189.62KB	Share
ACW Capital Raising
27/08/14	PRICE SENSITIVE	52.26KB	Share
ACW Actinogen to acquire Corticrine Limited
27/08/14	PRICE SENSITIVE	171.53KB	Share
ACW Trading Halt
26/08/14	PRICE SENSITIVE	106.11KB	Share
ACW Appendix 4E & Financial Statements
01/08/14	PRICE SENSITIVE	1.22MB	Share
ACW Appendix 4C & Commentary
31/07/14	PRICE SENSITIVE	140.87KB	Share
ACW Actinogen Isolates Demonstrate Antitumorigenic Activity
13/06/14	PRICE SENSITIVE	40.6KB	Share
ACW Appendix 4C & Commentary
16/04/14	PRICE SENSITIVE	131.49KB	Share
ACW Appendix 4D & Half-Year Financial Statements
27/02/14	PRICE SENSITIVE	504.02KB	Share
ACW Actinogen & Curtin Uni to Work on Cancer Stem Cells
27/02/14	PRICE SENSITIVE	34.07KB	Share
ACW TRIALS RECOMMENCE ON ANTIBIOTIC PROJECT
12/02/14	PRICE SENSITIVE	115.11KB	Share
ACW Appendix 4C & Commentary
23/01/14	PRICE SENSITIVE	107.89KB	Share
ACW +FGHActinogen Ltd Collaboration
23/12/13	PRICE SENSITIVE	492.26KB	Share
ACW +FGHLeaf to Fund First Trial on Actingoen's Bioethanol Project
23/12/13	PRICE SENSITIVE	34.84KB	Share
ACW Placement, Appendix 3B & Section 708A Notice
12/12/13	PRICE SENSITIVE	195.94KB	Share
ACW R&D Tax Rebate Received
28/11/13	PRICE SENSITIVE	44.9KB	Share
ACW Activity Report & Appendix 4C
29/10/13	PRICE SENSITIVE	127.53KB	Share
ACW Closure of laboratory
12/09/13	PRICE SENSITIVE	57.22KB	Share
ACW Actinogen to receive further funding from Otsana Capital
11/09/13	PRICE SENSITIVE	87.74KB	Share
ACW Preliminary Final Report
30/08/13	PRICE SENSITIVE	183.66KB	Share
ACW Market Update and Clarification
29/08/13	PRICE SENSITIVE	1.2MB	Share
ACW Suspension of ACWN and ACWO 1/08/13
01/08/13	PRICE SENSITIVE	79.81KB	Share
ACW Appendix 4C - quarterly
31/07/13	PRICE SENSITIVE	144.03KB	Share
ACW Supplementary prospectus - withdrawal of offer
31/07/13	PRICE SENSITIVE	121.26KB	Share
ACW Rights Issue Prospectus
02/07/13	PRICE SENSITIVE	1.43MB	Share
ACW Announcement of non-renounceable rights issue
01/07/13	PRICE SENSITIVE	82.39KB	Share
ACW New Discovery for Plant Growth in Wheat, Peas and Broad Bean
18/06/13	PRICE SENSITIVE	4.55MB	Share
ACW Response to ASX Appendix 4C query
10/05/13	PRICE SENSITIVE	4.69MB	Share
ACW Appendix 4C - quarterly
30/04/13	PRICE SENSITIVE	144.23KB	Share
ACW Independent trials being conducted on Plant Growth Hormones
27/03/13	PRICE SENSITIVE	4.56MB	Share
ACW Appendix 4D and Half Year Accounts
28/02/13	PRICE SENSITIVE	344.06KB	Share
ACW Appendix 4C - quarterly
31/01/13	PRICE SENSITIVE	143.83KB	Share
ACW Response to ASX Appendix 4C Query
19/11/12	PRICE SENSITIVE	4.69MB	Share
ACW Appendix 4C - quarterly
29/10/12	PRICE SENSITIVE	143.07KB	Share
ACW Preliminary Final Report
31/08/12	PRICE SENSITIVE	60.28KB	Share
ACW Response to Appendix 4C ASX Query
13/08/12	PRICE SENSITIVE	4.69MB	Share
ACW Appendix 4C - quarterly
27/07/12	PRICE SENSITIVE	57.23KB	Share
ACW New Discovery of Making Shikimic Acid
25/07/12	PRICE SENSITIVE	4.56MB	Share
ACW NEW PATENT APPLICATION FOR BIOFUMIGATION PROCESS
21/05/12	PRICE SENSITIVE	180.21KB	Share
ACW Rights issue closure and notice of remaining shortfall
16/05/12	PRICE SENSITIVE	208.64KB	Share
ACW Further results in bio-ethanol test program
01/05/12	PRICE SENSITIVE	510.58KB	Share
ACW Appendix 4C - quarterly
26/04/12	PRICE SENSITIVE	160.9KB	Share
ACW Supplementary prospectus and amended timetable
12/04/12	PRICE SENSITIVE	69.76KB	Share
ACW Rights issue prospectus (with amended timetable)
27/03/12	PRICE SENSITIVE	1.31MB	Share
ACW Rights Issue Prospectus
22/03/12	PRICE SENSITIVE	1.3MB	Share
ACW Bio-ethanol Commercialisation Strategy
20/03/12	PRICE SENSITIVE	427.09KB	Share
ACW Appendix 4D and Half Yearly Accounts
29/02/12	PRICE SENSITIVE	2.45MB	Share
ACW Response to ASX query
10/02/12	PRICE SENSITIVE	300KB	Share
ACW BIOFUEL PROGRAM UPDATE
31/01/12	PRICE SENSITIVE	71.6KB	Share
ACW Appendix 4C - quarterly
27/01/12	PRICE SENSITIVE	61.97KB	Share
ACW Update on the Biofuel Research Program
07/12/11	PRICE SENSITIVE	932.08KB	Share
ACW Actinogen New Discovery in the Biofuel Research Program
09/11/11	PRICE SENSITIVE	189.44KB	Share
ACW Appendix 4C - quarterly
27/10/11	PRICE SENSITIVE	160.49KB	Share
ACW Shareholder Update
03/10/11	PRICE SENSITIVE	177.68KB	Share
ACW Preliminary Final Report
30/08/11	PRICE SENSITIVE	363.44KB	Share
ACW Appendix 4C - quarterly
29/07/11	PRICE SENSITIVE	61.07KB	Share
ACW Appendix 4C - quarterly
29/04/11	PRICE SENSITIVE	137.03KB	Share
ACW Appendix 4D Half Yearly Report and Accounts
28/02/11	PRICE SENSITIVE	839.78KB	Share
ACW Appendix 4C - quarterly
31/01/11	PRICE SENSITIVE	57.78KB	Share
ACW Appendix 4C - quarterly
29/10/10	PRICE SENSITIVE	57.17KB	Share
ACW Range of Patented Biodegradable Nappies etc to be developed
22/10/10	PRICE SENSITIVE	64.25KB	Share
ACW Non-Renounceable Rights Issue and Prospectus
08/10/10	PRICE SENSITIVE	1.07MB	Share
ACW Actinogen scales up Anacardic Acid production
09/09/10	PRICE SENSITIVE	41.82KB	Share
ACW Preliminary Final Report - Appendix 4E
01/09/10	PRICE SENSITIVE	157.59KB	Share
ACW Discovery of New Method to produce Anacardic Acid
03/08/10	PRICE SENSITIVE	34.21KB	Share
ACW Appendix 4C - quarterly
29/07/10	PRICE SENSITIVE	57.03KB	Share
ACW Appendix 4C - quarterly
29/04/10	PRICE SENSITIVE	57.18KB	Share
ACW Appendix 4D Half Yearly Report and Accounts
25/02/10	PRICE SENSITIVE	198.23KB	Share
ACW New Biodegradable Shopping Bags and many other products
11/02/10	PRICE SENSITIVE	80.42KB	Share
ACW Appendix 4C - quarterly
29/01/10	PRICE SENSITIVE	57.04KB	Share
ACW Appendix 4C - quarterly
30/10/09	PRICE SENSITIVE	152.94KB	Share
ACW Preliminary Final Report - Appendix 4E
31/08/09	PRICE SENSITIVE	384.97KB	Share
ACW Quarterly Appendix 4C
31/07/09	PRICE SENSITIVE	62.46KB	Share
ACW Appendix 4C - quarterly
30/04/09	PRICE SENSITIVE	147.71KB	Share
ACW Half Yearly Report and Accounts
26/02/09	PRICE SENSITIVE	193.55KB	Share
ACW Appendix 4C - quarterly
30/01/09	PRICE SENSITIVE	37.69KB	Share

REFRESH

First 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.8¢		Change -0.001(1.79%)		Mkt cap ! $85.73M

Open	High	Low	Value	Volume
2.9¢	2.9¢	2.7¢	$63.47K	2.268M

Buyers (Bids)

No.	Vol.	Price($)
5	907600	2.7¢

Sellers (Offers)

Price($)	Vol.	No.
2.8¢	535081	2

View Market Depth

No.	Vol.	Price($)
5	907600	0.027
7	2748855	0.026
15	4176589	0.025
7	1984166	0.024
7	1766800	0.023

Price($)	Vol.	No.
0.028	535081	2
0.029	2194301	9
0.030	2943695	7
0.031	604999	4
0.032	514250	5

Last trade - 14.53pm 12/09/2025 (20 minute delay)


Last 2.7¢		Change -0.001 ( 5.59 %)
Open	High	Low	Volume
2.8¢	2.8¢	2.7¢	1775260
Last updated 15.57pm 12/09/2025 ?

ACW (ASX) Chart

ACTINOGEN MEDICAL LIMITED - Announcements

Corporate Spotlight

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories